2017 U.S.-Booked Air Volume: $104 million
Consolidated Global TMC: Amex GBT
BTN estimates that spending on U.S.-booked air travel for
pharmaceutical giant Sanofi increased less than 1 percent in 2017. Sanofi
continues to minimize travel spend and travel-related carbon emissions. The
company's global travel policy, in fact, recommends that before any business
trip, the feasibility of a virtual meeting must be assessed. Sanofi helps to
facilitate such meetings by offering in-house high-definition videoconferencing
and telepresence rooms throughout the world. Additionally, when certain
criteria are selected in the company's booking tool, the tool will prompt
travelers to consider travel alternatives. The company's business air travel,
hotel and rental car use generated about 111,440 metric tons of carbon dioxide
in 2017, an increase of about 1 percent year over year. Sanofi at year-end 2017
employed 106,566; that 293 fewer than one year earlier. The company's net sales
increased 3.6 percent in 2017 to 35.1 billion euros. In 2018, Sanofi has
acquired biotechnology firms Bioverativ and Ablynx.